Insitro Announces $143 Million Raised In Series B Financing
Insitro Inc., which operates a drug discovery and development platform that uses machine learning to compile biological data and predict human clinical outcomes, said Tuesday it has secured $143 million from...To view the full article, register now.
Already a subscriber? Click here to view full article